In this regard, our results show that silibinin strongly decreases the pro-tumorigenic effects of cytokines by reducing both the percentage of colon CSC and colonosphere formation, which were mediated via blocking of IL-4/-6 signaling by silibinin in different CRC cell lines. Here, IL4 is linked to colorectal carcinoma.